Federation des caisses Desjardins du Quebec’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-3,460
| Closed | -$3.07K | – | 2421 |
|
2022
Q4 | $3.07K | Sell |
3,460
-1,000
| -22% | -$886 | ﹤0.01% | 2136 |
|
2022
Q3 | $7K | Hold |
4,460
| – | – | ﹤0.01% | 1998 |
|
2022
Q2 | $8.97K | Sell |
4,460
-1,540
| -26% | -$3.1K | ﹤0.01% | 1988 |
|
2022
Q1 | $14K | Sell |
6,000
-1,000
| -14% | -$2.33K | ﹤0.01% | 1925 |
|
2021
Q4 | $32.6K | Buy |
7,000
+1,000
| +17% | +$4.65K | ﹤0.01% | 1703 |
|
2021
Q3 | $45.8K | Hold |
6,000
| – | – | ﹤0.01% | 1624 |
|
2021
Q2 | $58.1K | Sell |
6,000
-4,300
| -42% | -$41.7K | ﹤0.01% | 1567 |
|
2021
Q1 | $85.2K | Buy |
10,300
+7,800
| +312% | +$64.5K | ﹤0.01% | 1392 |
|
2020
Q4 | $17.1K | Sell |
2,500
-500
| -17% | -$3.41K | ﹤0.01% | 1781 |
|
2020
Q3 | $33.5K | Buy |
3,000
+1,500
| +100% | +$16.7K | ﹤0.01% | 1351 |
|
2020
Q2 | $9.42K | Buy |
+1,500
| New | +$9.42K | ﹤0.01% | 1654 |
|